Acute pulmonary embolism in COVID-19 related hypercoagulability

Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromb...

Full description

Saved in:
Bibliographic Details
Published in:Journal of thrombosis and thrombolysis Vol. 50; no. 1; pp. 223 - 226
Main Authors: Lorenzo, Cerruti, Francesca, Boscaro, Francesco, Poletto, Elena, Campello, Luca, Spiezia, Paolo, Simioni
Format: Journal Article
Language:English
Published: New York Springer US 01.07.2020
Springer Nature B.V
Subjects:
Cardiology
Case reports
Computed Tomography Angiography
Coronavirus Infections - complications
Coronaviruses
COVID-19
Embolism
Health risk assessment
Hematology
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Pandemics
Pneumonia
Pneumonia, Viral - complications
Prophylaxis
Pulmonary Embolism - diagnostic imaging
Pulmonary Embolism - virology
Pulmonary embolisms
Respiratory failure
Severe acute respiratory syndrome coronavirus 2
Thromboembolism
Thrombophilia - complications
Thrombophilia - virology
COVID-19
Pulmonary embolism
SARS-CoV-2
Case report
Interstitial pneumonia
Coagulation
ISSN:0929-5305, 1573-742X, 1573-742X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0929-5305
1573-742X
1573-742X
DOI:10.1007/s11239-020-02160-1